Bank of America
INBX icon

Bank of America’s Inhibrx INBX Stock Holding History

Bank of America’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.2M Sell
32,683
-36,436
-53% -$2.7M ﹤0.01% 4063
2025
Q4 		$5.46M Buy
69,119
+51,287
+288% +$3.49M ﹤0.01% 3321
2025
Q3 		$601K Buy
17,832
+8,702
+95% +$214K ﹤0.01% 5668
2025
Q2 		$130K Buy
9,130
+1,469
+19% +$19K ﹤0.01% 6384
2025
Q1 		$107K Sell
7,661
-4,769
-38% -$64.8K ﹤0.01% 6462
2024
Q4 		$191K Buy
12,430
+2,276
+22% +$34.7K ﹤0.01% 6143
2024
Q3 		$159K Buy
10,154
+243
+2% +$3.41K ﹤0.01% 6122
2024
Q2 		$140K Buy
+9,911
New +$155K ﹤0.01% 6075

Other funds holding INBX

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America's INBX Position: Q1 2026 in Review

Bank of America reduced its Inhibrx (INBX) stake by 53% in Q1 2026, selling an estimated $2.7M and leaving 32,683 shares worth $2.2M. The position accounts for ﹤0.01% of the portfolio, ranked #4063.

Bank of America first reported a position in INBX in Q2 2024 and has held it in 8 quarters since. The position peaked at $5.46M in Q4 2025. 135 funds tracked by Wall St. Rank hold INBX as of Q1 2026.

  • Bank of America held 32,683 shares of Inhibrx worth $2.2M as of Q1 2026.
  • Bank of America sold 36,436 Inhibrx shares in Q1 2026, an estimated $2.7M.
  • Inhibrx made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #4063 holding.
  • Bank of America first reported a position in Inhibrx in Q2 2024 and has held it in 8 quarters since.
  • Bank of America's Inhibrx position peaked at $5.46M in Q4 2025.
  • 135 funds tracked by Wall St. Rank held Inhibrx as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.